69LYON, C Bérard, Onco
Lyon
0 studies enrolling now · 2 studies all time
What they study most
Advanced Ovarian Cancer, BRCA Mutated, BRCA Mutation, Complete Response, FIGO Stage III-IV, First Line Platinum Chemotherapy, Following Complete or Partial Response to Platinum Based Chemotherapy, Newly Diagnosed, Partial Response, Platinum Sensitive, Relapsed Ovarian Cancer